Ledger.Open graph →
SEC Form D · Amendment · filed July 9, 2019

CARISMA Therapeutics Inc

Offering
$54.2M
Sold
$29.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Suren Dutia · Franklin Lakes, NJDirectorTony Padgett · San Antonio, TXDirectorHy Levitsky · Philadelphia, PADirectorRobert Scofield · San Antonio, TXDirectorBrennen Degner · PLAYA VISTA, CADirectorMadhav Krishna · Franklin Lakes, NJDirectorDan Rabinowitz · San Antonio, TXDirectorMike Kienitz · San Antonio, TXExec · DirectorRishi Srivastava · Franklin Lakes, NJDirectorLaura Velarde · San Antonio, TXDirectorPatrick Reilly · Brighton, MAExec · DirectorMarty Neese · SAN ANTONIO, TXDirectorDevin Antin · PLAYA VISTA, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗